1Whee|erCM.Natural history of human papillomavirus infections, cyto|ogicAnd histologic abnormalities, and cancer[J].Obstet Gynecol Clin North Am, 2008,35 (4): 519-536.
4Parkin DM, Bray F, Ferlay J. et al. Global cancer statistics, 2002[J]. CA Cancer J Clin,2005,55(2) :74-108.
5Zur Hausen H. Condylomata acuminata and human genital cancer [J].Cancer Res, 1976,36(2part 2) :794.
6Munox N, Bosh FX, de Sampose' S, et al. Epidemiologic classi- fication of human papillomavirus types associated with cervica cancer[J]. N Engl J Med, 2003,348(6) :518-527.
7李力.宫颈癌[M].丰有吉,沈铿.妇产科学.2版.北京:人民卫生出版,2010:325-331.
8World Health Organization. Vaccine position papers on human papillomavirus vaccine[J]. WER, 2008,58 (15) : 118-131.
9Lu B, Kumar A, Castellsague X, et al. Efficacy and safely of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & Meta analysis[J]. BMC Infect Dis,2011,11(1):1- 16.
10Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine[J]. N Engl J Med, 2002,347(21) : 1645- 1651.
